What Apple, which is worth $3.5 trillion, wanted was an injunction on the sales of Masimo‘s current smartwatch models. However, the jury determined that those newer models don’t violate Apple’s intellectual property. That is why Masimo is also treating the jury’s decision as a win, telling the news organization that it’s thankful for the verdict that’s “in favor of Masimo and against Apple on nearly all issues.” Apparently, the ruling only affects a “discontinued module and charger.” As for Apple, it told Reuters that it was “glad the jury’s decision today will protect the innovations [it advances] on behalf of [its] customers.”
Masimo sued Apple in 2021, accusing it of infringing on several of its light-based blood-oxygen monitoring patents, while the tech giant countersued a year later. A court sided with Masimo in 2023, forcing Apple to pause sales on its latest smartwatch models, as the US International Trade Commission blocked all Watch Series 9 and Ultra 2 imports into the country. The company appealed and was ultimately able to sell its watches in the country earlier this year by removing the technology from the units offered in the US.